OR5AP2 inhibitors are a class of chemical compounds that interact with the olfactory receptor OR5AP2, a G protein-coupled receptor (GPCR) belonging to the olfactory receptor family. These receptors, primarily known for their role in detecting odorant molecules, are part of a larger network of GPCRs that transduce extracellular signals through activation of intracellular G proteins. OR5AP2, like other olfactory receptors, is involved in the molecular recognition of specific ligands. By inhibiting OR5AP2, these compounds disrupt the receptor's ability to bind its ligands or prevent the subsequent signal transduction cascade that would normally result from ligand-receptor interactions. This inhibition could lead to alterations in the receptor's native functional pathways, especially those related to sensory signal processing, though OR5AP2 may also have roles in non-olfactory tissues, as is sometimes seen with other olfactory receptors.
Chemically, OR5AP2 inhibitors may feature a range of structural motifs, depending on the nature of the target receptor's binding site. The development of these inhibitors often involves structure-activity relationship (SAR) studies to refine their specificity and efficacy in selectively binding to OR5AP2 without affecting other olfactory or non-olfactory GPCRs. These studies help identify functional groups or molecular scaffolds that are most effective at binding to OR5AP2's active or allosteric sites. The mechanisms of inhibition can vary between competitive, non-competitive, or allosteric, depending on the specific interaction between the inhibitor and the receptor. In the broader field of chemical biology, OR5AP2 inhibitors provide a tool to probe the molecular mechanisms of olfactory receptors, facilitating the study of how these receptors operate at a molecular level and contribute to the broader GPCR signaling landscape.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA at the transcription initiation complex, obstructing RNA polymerase action, which would downregulate OR5AP2 gene transcription. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide halts eukaryotic protein synthesis at the translation stage, potentially leading to a decrease in OR5AP2 protein synthesis if translation is prematurely terminated. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C forms covalent crosslinks with DNA, which could obstruct the replication fork and transcription machinery, resulting in a reduced transcription of the OR5AP2 gene. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to G-C rich DNA sequences, which may directly interfere with the binding of transcription factors to the OR5AP2 promoter region, leading to decreased OR5AP2 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is crucial for cell growth and protein synthesis; this inhibition could lead to a reduced synthesis of OR5AP2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporation into DNA disrupts methylation patterns, potentially leading to the repression of OR5AP2 gene transcription by altering chromatin structure. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can cause hyperacetylation of histones, leading to a relaxed chromatin structure that might be less conducive to OR5AP2 gene transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine intercalates into DNA and RNA, which can inhibit DNA replication and RNA synthesis, potentially leading to a reduced transcriptional output of the OR5AP2 gene. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 inhibits BET bromodomains, which could lead to the downregulation of transcriptional programs including those responsible for the expression of the OR5AP2 gene. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD 98059 selectively inhibits MEK1/2 enzymes, which could lead to a decrease in the phosphorylation of transcription factors essential for OR5AP2 gene transcription. | ||||||